Halma (LON:HLMA) Stock Rating Reaffirmed as “Hold” by Jefferies Financial Group

Halma (LON:HLMA)‘s stock had its “hold” rating reaffirmed by research analysts at Jefferies Financial Group in a research note issued to investors on Friday, Digital Look reports. They currently have a GBX 3,660 price objective on the stock. Jefferies Financial Group’s price target would indicate a potential upside of 5.05% from the stock’s previous close.

HLMA has been the topic of a number of other research reports. Berenberg Bank reissued a “buy” rating and issued a GBX 4,200 target price on shares of Halma in a research note on Thursday, July 16th. Citigroup increased their price target on shares of Halma from GBX 3,700 to GBX 4,600 and gave the stock a “buy” rating in a research report on Friday, June 12th. Finally, UBS Group restated a “buy” rating and set a £47,750 price target on shares of Halma in a research note on Friday, June 5th. Five research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Halma currently has a consensus rating of “Moderate Buy” and an average target price of £6,003.71.

Halma Stock Performance

Shares of HLMA stock opened at GBX 3,484 on Friday. The firm has a fifty day moving average of GBX 3,602.58 and a 200-day moving average of GBX 3,959.45. The stock has a market cap of £13.16 billion, a price-to-earnings ratio of 35.49, a P/E/G ratio of 2.93 and a beta of 0.97. Halma has a 52-week low of GBX 3,268 and a 52-week high of GBX 4,902. The company has a debt-to-equity ratio of 42.13, a quick ratio of 1.51 and a current ratio of 2.14.

Insider Buying and Selling at Halma

In other Halma news, insider Jennifer Ward sold 13,145 shares of the stock in a transaction on Thursday, July 23rd. The stock was sold at an average price of GBX 3,645, for a total transaction of £479,135.25. Also, insider Marc Ronchetti sold 47,000 shares of Halma stock in a transaction on Friday, August 7th. The shares were sold at an average price of GBX 3,813, for a total value of £1,792,110. Insiders have sold 62,393 shares of company stock valued at $235,309,493 over the last quarter. Corporate insiders own 0.82% of the company’s stock.

Trending Headlines about Halma

Here are the key news stories impacting Halma this week:

• Positive Sentiment: Halma raised its full-year FY2027 adjusted EBIT margin guidance after a strong first half. Management cited robust trading, contributions from recent acquisitions and continued demand in safety, healthcare and environmental markets. Halma lifts margin guidance as record dealmaking fuels growth
• Positive Sentiment: Revenue reportedly increased 15%, helped by the Pyxis acquisition and other dealmaking. Halma has spent approximately £515 million on acquisitions, strengthening its growth platform and supporting the improved profitability outlook. Halma stock reports 15 percent revenue growth after Pyxis deal
• Positive Sentiment: Investors also responded to evidence that photonics and recent acquisitions are driving growth, although the company’s photonics outlook itself was left unchanged. Halma lifts profit margin guidance as photonics and dealmaking drive growth
• Neutral Sentiment: Jefferies reaffirmed its “hold” rating and set a GBX 3,660 price target. The target suggests some potential upside from recent trading levels, but the unchanged rating indicates that the broker sees a relatively balanced risk-reward profile.
• Negative Sentiment: The stock’s valuation remains demanding, with a reported price-to-earnings ratio above 35, while its shares are below both the 50-day and 200-day moving averages. Investors may also be concerned about integrating the acquisition pipeline and converting substantial deal spending into sustained organic growth.

About Halma

Halma is a global group of life-saving technology companies, focused on growing a safer, cleaner, healthier future for everyone, every day. Its purpose defines the three broad markets it operates in:

– Safety – Protecting people’s safety and the environment as populations grow, and enhancing worker safety.
– Environment – Addressing the impacts of climate change, pollution and waste, protecting life-critical resources and supporting scientific research.
– Health – Meeting the increasing demand for better healthcare as chronic illness rises, driven by growing and ageing populations and lifestyle changes.

Halma employs over 9,000 people in more than 20 countries, with major operations in the UK, Mainland Europe, the USA and Asia Pacific.